Pulse Biosciences (Nasdaq:PLSE) today announced the

LivaNova (NASDAQ: LIVN)+
says it’s the latest victim of a cybersecurity incident.

FORT MILL, SC / ACCESSWIRE / November 20, 2023 / Catheter Precision, Inc. (the “Company”) (NYSE American:VTAK), a pioneering medical technology firm headquartered in the United States, specializing in electrophysiology devices, has proudly disclosed the successful conclusion of the inaugural VIVO cases in the region of South-Eastern Europe. VIVO, the Company’s innovative 3D non-invasive imaging system, is used pre-procedurally to identify areas of interest for ventricular ablation and aid in pre-procedure planning to reduce procedure time and aid in procedural accuracy.

ST. PAUL, Minn.–(BUSINESS WIRE)– Cardio Flow, Inc., a privately held commercial-stage medical device company and developer of minimally invasive devices to treat peripheral artery disease (PAD), is pleased to announce the successful completion of its first commercial cases for its FreedomFlow® Orbital Atherectomy Platform following FDA clearance in late September.

While useful for killing pathogens including SARS-CoV-2, the lights may cause unwanted chemical reactions and should be used with ventilation, researchers say.